CAS
LLY icon

Coppell Advisory Solutions’s Eli Lilly LLY Stock Holding History

Coppell Advisory Solutions’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,363
Closed -$1.47M – 215
2025
Q4 		$1.47M Buy
1,363
+729
+115% +$697K 0.14% 140
2025
Q3 		$461K Buy
634
+276
+77% +$205K 0.05% 262
2025
Q2 		$278K Buy
+358
New +$278K 0.03% 306
2025
Q1 		– Sell
-102
Closed -$78.9K – 1184
2024
Q4 		$78.9K Sell
102
-194
-66% -$161K 0.01% 475
2024
Q3 		$260K Sell
296
-26,480
-99% -$23.8M 0.04% 237
2024
Q2 		$24.2M Buy
+26,776
New +$21.4M 4% 5
2023
Q4 		$257K Buy
441
+434
+6,200% +$253K 0.05% 229
2023
Q3 		$2.56K Sell
7
-40
-85% -$20.6K ﹤0.01% 819
2023
Q2 		$21.8K Buy
+47
New +$19.7K 0.01% 544
2023
Q1 		– Sell
-7
Closed -$2.56K – 694
2022
Q4 		$2.56K Buy
+7
New +$2.48K ﹤0.01% 819

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Coppell Advisory Solutions's LLY Position: Q1 2026 in Review

Coppell Advisory Solutions sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,363 shares — an estimated $1.47M sold.

Coppell Advisory Solutions first reported a position in LLY in Q4 2022 and held it in 10 quarters. The position peaked at $24.2M in Q2 2024. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Coppell Advisory Solutions reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Coppell Advisory Solutions sold 1,363 Eli Lilly shares in Q1 2026, an estimated $1.47M.
  • Coppell Advisory Solutions first reported a position in Eli Lilly in Q4 2022 and held it in 10 quarters.
  • Coppell Advisory Solutions's Eli Lilly position peaked at $24.2M in Q2 2024.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Coppell Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.